Trials / Withdrawn
WithdrawnNCT04472091
Genicular Artery Embolization (GAE) for Osteoarthritic Knee Pain
Genicular Artery Embolization for the Treatment of Moderate to Severe Osteoarthritic Knee Pain
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Andrew Picel · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this investigation is to evaluate the safety of the geniculate artery embolization (GAE) procedure with HydroPearl® Microspheres in 30 patients with knee pain caused by osteoarthritis with 24 months follow-up. The GAE procedure is an arterial embolization procedure that blocks abnormal blood vessels caused be knee arthritis in order to evaluate the effect on knee pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Genicular artery embolization (GAE) | Participants will undergo GAE with HydroPearl® Microspheres (polyethylene glycol microspheres, Terumo Medical, Somerset NJ). |
Timeline
- Start date
- 2025-01-15
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
- First posted
- 2020-07-15
- Last updated
- 2025-02-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04472091. Inclusion in this directory is not an endorsement.